Literature DB >> 7899242

Effect of 2-hydroxypropyl-beta-cyclodextrin on crystallization and polymorphic transition of nifedipine in solid state.

F Hirayama1, Z Wang, K Uekama.   

Abstract

The glassy state of nifedipine (NP) was prepared in the absence and presence of 2-hydroxypropyl-beta-cyclodextrin (HP-beta-CyD), and its crystallization and polymorphic transition behavior was investigated by differential scanning calorimetry (DSC) and powder X-ray diffractometry. In DSC thermograms, the glassy NP exhibited an endothermic peak at 48 degrees C representing the glass transition of NP, an exothermic peak at 105 degrees C for the crystallization to a metastable form of NP (Form B), an exothermic peak at 125 degrees C for the polymorphic transition of Form B to a stable form of NP (Form A), and an endothermic peak at 171 degrees C for the melting of Form A. The powder X-ray diffractogram of Form B was apparently different from that of Form A. In the presence of HP-beta-CyD, the exothermic peak at 125 degrees C for the Form B to A transition disappeared and a new endothermic peak appeared at 163 degrees C. This new peak was ascribed to the melting of Form B, and the conversion of Form B to Form A was significantly suppressed in HP-beta-CyD matrix. Upon storage at 60 degrees C, the glassy NP was converted to Form A with an activation energy of 18 kcal/mol. The apparent dissolution rate of the NP/HP-beta-CyD (molar ratio 1:1) increased in the order of glassy NP < Form A < Form B, because the glassy NP was readily converted to Form A upon contact with water, resulting in a lower dissolution rate.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7899242     DOI: 10.1023/a:1018971501909

Source DB:  PubMed          Journal:  Pharm Res        ISSN: 0724-8741            Impact factor:   4.200


  10 in total

1.  Characterization of habits and crystalline modification of solids and their pharmaceutical applications.

Authors:  J K Haleblian
Journal:  J Pharm Sci       Date:  1975-08       Impact factor: 3.534

Review 2.  Review on crystal polymorphism of substances in the European pharmacopoeia.

Authors:  L Borka
Journal:  Pharm Acta Helv       Date:  1991

3.  [On polymorphic forms of nifedipine from supercooled melts (author's transl)].

Authors:  T Eckert; J Müller
Journal:  Arch Pharm (Weinheim)       Date:  1977-02       Impact factor: 3.751

4.  A kinetic study on the isothermal transition of polymorphic forms of tolbutamide and mefenamic acid in the solid state at high temperatures.

Authors:  T Umeda; N Ohnishi; T Yokoyama; T Kuroda; Y Kita; K Kuroda; E Tatsumi; Y Matsuda
Journal:  Chem Pharm Bull (Tokyo)       Date:  1985-05       Impact factor: 1.645

5.  Identification of nifedipine metabolites and their determination by gas chromatography.

Authors:  S Kondo; A Kuchiki; K Yamamoto; K Akimoto; K Takahashi; N Awata; I Sugimoto
Journal:  Chem Pharm Bull (Tokyo)       Date:  1980-01       Impact factor: 1.645

6.  Effect of polymorphism on the absorption of chloramphenicol from chloramphenicol palmitate.

Authors:  A J Aguiar; J Krc; A W Kinkel; J C Samyn
Journal:  J Pharm Sci       Date:  1967-07       Impact factor: 3.534

7.  Inhibitory effect of 2-hydroxypropyl-beta-cyclodextrin on crystal-growth of nifedipine during storage: superior dissolution and oral bioavailability compared with polyvinylpyrrolidone K-30.

Authors:  K Uekama; K Ikegami; Z Wang; Y Horiuchi; F Hirayama
Journal:  J Pharm Pharmacol       Date:  1992-02       Impact factor: 3.765

8.  Crystal structures of calcium channel antagonists: 2,6-dimethyl-3,5-dicarbomethoxy-4-[2-nitro-, 3-cyano-, 4-(dimethylamino)-, and 2,3,4,5,6-pentafluorophenyl]-1,4-dihydropyridine.

Authors:  A M Triggle; E Shefter; D J Triggle
Journal:  J Med Chem       Date:  1980-12       Impact factor: 7.446

Review 9.  Cyclodextrins in drug carrier systems.

Authors:  K Uekama; M Otagiri
Journal:  Crit Rev Ther Drug Carrier Syst       Date:  1987       Impact factor: 4.889

10.  In-vivo and in-vitro evaluations of a modified-release oral dosage form of nifedipine by hybridization of hydroxypropyl-beta-cyclodextrin and hydroxypropylcelluloses in dogs.

Authors:  Z Wang; F Hirayama; K Uekama
Journal:  J Pharm Pharmacol       Date:  1994-06       Impact factor: 3.765

  10 in total
  4 in total

1.  Crystallization of organic glasses: effects of polymer additives on bulk and surface crystal growth in amorphous nifedipine.

Authors:  Ting Cai; Lei Zhu; Lian Yu
Journal:  Pharm Res       Date:  2011-06-03       Impact factor: 4.200

2.  A kinetic study of the polymorphic transformation of nimodipine and indomethacin during high shear granulation.

Authors:  Zhen Guo; Mingxin Ma; Tianyi Wang; Di Chang; Tongying Jiang; Siling Wang
Journal:  AAPS PharmSciTech       Date:  2011-05-07       Impact factor: 3.246

3.  Improvement of dissolution behavior for poorly water-soluble drug by application of cyclodextrin in extrusion process: comparison between melt extrusion and wet extrusion.

Authors:  Hideki Yano; Peter Kleinebudde
Journal:  AAPS PharmSciTech       Date:  2010-05-22       Impact factor: 3.246

4.  Formation and Physico-Chemical Evaluation of Nifedipine-hydroxypropyl-β-cyclodextrin and Nifedipine-methyl-β-cyclodextrin: The Development of Orodispersible Tablets.

Authors:  Emma Adriana Ozon; Marian Novac; Daniela Gheorghe; Adina Magdalena Musuc; Mirela Adriana Mitu; Iulian Sarbu; Valentina Anuta; Adriana Rusu; Simona Petrescu; Irina Atkinson; Dumitru Lupuliasa
Journal:  Pharmaceuticals (Basel)       Date:  2022-08-12
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.